Rislenemdaz
Rislenemdaz (CERC-301) is a selective GluN2B subunit-containing NMDA receptor antagonist. This compound is a valuable research tool for investigating the role of these receptors in neurological disorders, supporting both in vitro binding studies and in vivo preclinical models.
Product Specifications
CAS Number
808732-98-1
Product Name Alternative
NR2B N-methyl-D-aspartate, MK 0657, MK0657, MK-0657, GluN2B, CERC 301, CERC301, CERC-301, Rislenemdaz
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.18% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (9.21 mM) ; DMSO:90 mg/mL (251.11 mM)
Smiles
Cc1ccc (COC (=O) N2CC[C@H] (CNc3ncccn3) [C@H] (F) C2) cc1
Molecular Formula
C19H23FN4O2
Molecular Weight
358.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL516179V 500 µL Each
Slc35b4 Mouse shRNA Lentiviral Particle (Locus ID 58246)
Sign In for Pricing
View Details BSKH63685-01 48 Tests
Human Heat Shock 70kDa Protein 5 (HSPA5) ELISA Kit
Sign In for Pricing
View Details BSKH63685-02 96 Tests
Human Heat Shock 70kDa Protein 5 (HSPA5) ELISA Kit
Sign In for Pricing
View Details